| scholarly article | Q13442814 |
| P2093 | author name string | N T Maidment | |
| B L Kieffer | |||
| H W Matthes | |||
| P D Skoubis | |||
| W M Walwyn | |||
| P2860 | cites work | Aversive effects of naltrexone in subjects not dependent on opiates | Q49119530 |
| Disturbances of neophobia and taste-aversion learning after bilateral kainate microlesions in the rat pallidum. | Q51106166 | ||
| Effects of naloxone on diurnal rhythms in mood and endocrine function: a dose-response study in man. | Q51134765 | ||
| Assessment of SNC 80 and naltrindole within a conditioned taste aversion design. | Q52165522 | ||
| Possible routes of visceral information in the rat brain in formation of conditioned taste aversion. | Q52173306 | ||
| Aversive properties of opiate receptor blockade: evidence for exclusively central mediation in naive and morphine-dependent rats. | Q52249161 | ||
| Reinforcing properties of morphine and naloxone revealed by conditioned place preferences: a procedural examination. | Q52277966 | ||
| Further evidence that naloxone acts as an inverse opiate agonist: implications for drug dependence and withdrawal | Q71219901 | ||
| G-protein-coupled receptor heterodimerization modulates receptor function | Q24603239 | ||
| Constitutive activity of the delta-opioid receptor expressed in C6 glioma cells: identification of non-peptide delta-inverse agonists | Q28343629 | ||
| Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses | Q28510086 | ||
| Drug abuse: hedonic homeostatic dysregulation | Q29615904 | ||
| Constitutive activation of the delta opioid receptor by mutations in transmembrane domains III and VII. | Q33865332 | ||
| Opioids and their complicated receptor complexes | Q34047403 | ||
| A potent and selective endogenous agonist for the mu-opiate receptor | Q34420509 | ||
| Effects of naloxone on experimentally induced ischemic pain and on mood in human subjects | Q35014322 | ||
| Agonist induced constitutive receptor activation as a novel regulatory mechanism. Mu receptor regulation. | Q40478484 | ||
| Neural substrates for conditioned taste aversion in the rat. | Q40507266 | ||
| delta-Opioid receptor subtypes and cross-talk with mu-receptors | Q40853754 | ||
| Pharmacological delta1- and delta2-opioid receptor subtypes in the human neuroblastoma cell line SK-N-BE: no evidence for distinct molecular entities. | Q40897660 | ||
| The role of CRF in behavioral aspects of stress | Q40967890 | ||
| Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene | Q41157124 | ||
| Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal | Q41211959 | ||
| Some effects of naloxone on behavior in the mouse | Q41302623 | ||
| Constitutive mu opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence | Q41507059 | ||
| Self-administration of methionine enkephalin into the nucleus accumbens | Q41559926 | ||
| Involvement of opioid mu 1 receptors in morphine-induced conditioned place preference in rats | Q42548125 | ||
| Naloxone inhibits the reinforcing and motivational aspects of cocaine addiction in mice | Q42549918 | ||
| Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated | Q43705022 | ||
| Enhanced delta-opioid receptor-mediated antinociception in mu-opioid receptor-deficient mice | Q44330126 | ||
| Cocaine place preference is blocked by the delta-opioid receptor antagonist, naltrindole | Q44333032 | ||
| Involvement of central mu and delta opioid receptors in mediating the reinforcing effects of beta-endorphin in the rat. | Q44336761 | ||
| Lack of involvement of delta-opioid receptors in mediating the rewarding effects of cocaine | Q44341010 | ||
| Role of delta-opioid receptors in mediating the aversive stimulus effects of morphine withdrawal in the rat. | Q44342279 | ||
| Aversive property of opioid receptor blockade in drug-naive mice | Q44342657 | ||
| Involvement of beta-endorphin and mu-opioid receptors in mediating the aversive effect of lithium in the rat. | Q44343686 | ||
| The mu-opioid receptor is necessary for [D-Pen2,D-Pen5]enkephalin-induced analgesia | Q44345741 | ||
| Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning | Q44346240 | ||
| mu Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality | Q44348420 | ||
| Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor. | Q44349908 | ||
| Visceral chemical nociception in mice lacking mu-opioid receptors: effects of morphine, SNC80 and U-50,488. | Q44351535 | ||
| Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats. | Q48144276 | ||
| Motivational properties of opioids: evidence that an activation of delta-receptors mediates reinforcement processes | Q48171483 | ||
| Role of the medial and lateral parabrachial nucleus in acquisition and retention of conditioned taste aversion in rats | Q48433468 | ||
| Aversive properties of naloxone in non-dependent (naive) rats may involve blockade of central beta-endorphin | Q48583958 | ||
| Endogenous opiate reward induced by an enkephalinase inhibitor, thiorphan, injected into the ventral midbrain | Q48687272 | ||
| Dopaminergic mediation of reward produced by direct injection of enkephalin into the ventral tegmental area of the rat. | Q48704092 | ||
| Drug reinforcement studied by the use of place conditioning in rat | Q48922550 | ||
| Reward produced by microinjection of (D-Ala2),Met5-enkephalinamide into the ventral tegmental area | Q48937041 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | opioid | Q427523 |
| P304 | page(s) | 757-763 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Neuroscience | Q15708571 |
| P1476 | title | Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice | |
| P478 | volume | 106 |
| Q42942034 | 14-O-Heterocyclic-substituted naltrexone derivatives as non-peptide mu opioid receptor selective antagonists: design, synthesis, and biological studies |
| Q24635916 | Activation of μ-opioid receptors in the dorsal striatum is necessary for adult social attachment in monogamous prairie voles |
| Q34957285 | Analgesic tone conferred by constitutively active mu opioid receptors in mice lacking β-arrestin 2 |
| Q30614491 | Behavioral architecture of opioid reward and aversion in C57BL/6 substrains |
| Q73578944 | Beta-phenylethylamines and the isoquinoline alkaloids |
| Q38743944 | Binding mode analyses of NAP derivatives as mu opioid receptor selective ligands through docking studies and molecular dynamics simulation |
| Q37317909 | Binding mode characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives via docking in opioid receptor crystal structures and site-directed mutagenesis studies: application of the 'message-address' concept in development of m |
| Q44341655 | Blockade of ventral pallidal opioid receptors induces a conditioned place aversion and attenuates acquisition of cocaine place preference in the rat. |
| Q44345244 | Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice |
| Q44346336 | Casein kinase 1-epsilon deletion increases mu opioid receptor-dependent behaviors and binge eating1. |
| Q44349419 | Constitutively active micro opioid receptors mediate the enhanced conditioned aversive effect of naloxone in morphine-dependent mice |
| Q35792592 | Differential involvement of endogenous opioids in sucrose consumption and food reinforcement |
| Q37129992 | Discriminative stimulus properties of naloxone in Long-Evans rats: assessment with the conditioned taste aversion baseline of drug discrimination learning |
| Q30499182 | Disruption of endogenous opioid activity during instrumental learning enhances habit acquisition. |
| Q44567461 | Distinct changes in the behavioural effects of morphine and naloxone in CCK2 receptor-deficient mice |
| Q35048784 | Endogenous opiates and behavior: 2001. |
| Q35688481 | Enkephalin downregulation in the nucleus accumbens underlies chronic stress-induced anhedonia. |
| Q98464765 | Evaluation of Biased and Balanced Salvinorin A Analogs in Preclinical Models of Pain |
| Q34641459 | Exploring the opioid system by gene knockout |
| Q43226849 | Forebrain PENK and PDYN gene expression levels in three inbred strains of mice and their relationship to genotype-dependent morphine reward sensitivity |
| Q88030717 | In vitro and in vivo functional profile characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3-carboxamido)morphinan (NAQ) as a low efficacy mu opioid receptor modulator |
| Q44288279 | Involvement of the kappa-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats |
| Q34164959 | Morphine self-administration following spinal cord injury |
| Q44341922 | Morphine withdrawal precipitated by specific mu, delta or kappa opioid receptor antagonists: a c-Fos protein study in the rat central nervous system |
| Q43269915 | Motivational effects of opiates in conditioned place preference and aversion paradigm--a study in three inbred strains of mice |
| Q90034363 | Mu opioid receptors in the medial habenula contribute to naloxone aversion |
| Q36985785 | NMDA Receptors on Dopaminoceptive Neurons Are Essential for Drug-Induced Conditioned Place Preference |
| Q89207660 | Opioid receptors: drivers to addiction? |
| Q34904385 | Pavlovian conditioning of multiple opioid-like responses in mice |
| Q48170689 | Prenatal exposure to valproic acid disturbs the enkephalinergic system functioning, basal hedonic tone, and emotional responses in an animal model of autism |
| Q43632330 | Restricted role of CRF1 receptor for the activity of brainstem catecholaminergic neurons in the negative state of morphine withdrawal |
| Q36805098 | Reversal effect of intra-central amygdala microinjection of L-arginine on place aversion induced by naloxone in morphine conditioned rats |
| Q34161442 | Skin β-endorphin mediates addiction to UV light |
| Q37363984 | Targeting endogenous mu- and delta-opioid receptor systems for the treatment of drug addiction |
| Q90107822 | The Negative Affect of Protracted Opioid Abstinence: Progress and Perspectives From Rodent Models |
Search more.